Preemptive kidney transplantation: why, when, and how?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Jornal Brasileiro de Nefrologia |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005048401 |
Resumo: | ABSTRACT Among renal replacement therapies, preemptive kidney transplantation (PKT) presents the best clinical, social, and economic results. However, it is still infrequently chosen as first therapy for patients with irreversible kidney failure. Initiatives in different parts of the world were developed to identify the reasons why PKT is still not widely used and to facilitate the access of patients with end-stage kidney disease to the advantages associated with it. This article addresses the main advantages and difficulties of PKT and discusses when it should be indicated and how to prepare potential recipients for PKT. |
id |
SBN-1_21033c8f187f0850dd61ca82a943314d |
---|---|
oai_identifier_str |
oai:scielo:S0101-28002022005048401 |
network_acronym_str |
SBN-1 |
network_name_str |
Jornal Brasileiro de Nefrologia |
repository_id_str |
|
spelling |
Preemptive kidney transplantation: why, when, and how?Preemptive Kidney TransplantationRenal Insufficiency, ChronicRenal Replacement TherapyABSTRACT Among renal replacement therapies, preemptive kidney transplantation (PKT) presents the best clinical, social, and economic results. However, it is still infrequently chosen as first therapy for patients with irreversible kidney failure. Initiatives in different parts of the world were developed to identify the reasons why PKT is still not widely used and to facilitate the access of patients with end-stage kidney disease to the advantages associated with it. This article addresses the main advantages and difficulties of PKT and discusses when it should be indicated and how to prepare potential recipients for PKT.Sociedade Brasileira de Nefrologia2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005048401Brazilian Journal of Nephrology n.ahead 2022reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.1590/2175-8239-jbn-2022-0085eninfo:eu-repo/semantics/openAccessMoura,Ana FláviaMoura-Neto,José A.Requião-Moura,Lucio R.Pacheco-Silva,Álvaroeng2022-09-26T00:00:00Zoai:scielo:S0101-28002022005048401Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2022-09-26T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false |
dc.title.none.fl_str_mv |
Preemptive kidney transplantation: why, when, and how? |
title |
Preemptive kidney transplantation: why, when, and how? |
spellingShingle |
Preemptive kidney transplantation: why, when, and how? Moura,Ana Flávia Preemptive Kidney Transplantation Renal Insufficiency, Chronic Renal Replacement Therapy |
title_short |
Preemptive kidney transplantation: why, when, and how? |
title_full |
Preemptive kidney transplantation: why, when, and how? |
title_fullStr |
Preemptive kidney transplantation: why, when, and how? |
title_full_unstemmed |
Preemptive kidney transplantation: why, when, and how? |
title_sort |
Preemptive kidney transplantation: why, when, and how? |
author |
Moura,Ana Flávia |
author_facet |
Moura,Ana Flávia Moura-Neto,José A. Requião-Moura,Lucio R. Pacheco-Silva,Álvaro |
author_role |
author |
author2 |
Moura-Neto,José A. Requião-Moura,Lucio R. Pacheco-Silva,Álvaro |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Moura,Ana Flávia Moura-Neto,José A. Requião-Moura,Lucio R. Pacheco-Silva,Álvaro |
dc.subject.por.fl_str_mv |
Preemptive Kidney Transplantation Renal Insufficiency, Chronic Renal Replacement Therapy |
topic |
Preemptive Kidney Transplantation Renal Insufficiency, Chronic Renal Replacement Therapy |
description |
ABSTRACT Among renal replacement therapies, preemptive kidney transplantation (PKT) presents the best clinical, social, and economic results. However, it is still infrequently chosen as first therapy for patients with irreversible kidney failure. Initiatives in different parts of the world were developed to identify the reasons why PKT is still not widely used and to facilitate the access of patients with end-stage kidney disease to the advantages associated with it. This article addresses the main advantages and difficulties of PKT and discusses when it should be indicated and how to prepare potential recipients for PKT. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005048401 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005048401 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/2175-8239-jbn-2022-0085en |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Nephrology n.ahead 2022 reponame:Jornal Brasileiro de Nefrologia instname:Sociedade Brasileira de Nefrologia (SBN) instacron:SBN |
instname_str |
Sociedade Brasileira de Nefrologia (SBN) |
instacron_str |
SBN |
institution |
SBN |
reponame_str |
Jornal Brasileiro de Nefrologia |
collection |
Jornal Brasileiro de Nefrologia |
repository.name.fl_str_mv |
Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN) |
repository.mail.fl_str_mv |
||jbn@sbn.org.br |
_version_ |
1752122067694649344 |